Literature DB >> 23754513

Oxygen nano-bubble water reduces calcium oxalate deposits and tubular cell injury in ethylene glycol-treated rat kidney.

Yasuhiko Hirose1, Takahiro Yasui, Kazumi Taguchi, Yasuhiro Fujii, Kazuhiro Niimi, Shuzo Hamamoto, Atsushi Okada, Yasue Kubota, Noriyasu Kawai, Yasunori Itoh, Keiichi Tozawa, Shoichi Sasaki, Kenjiro Kohri.   

Abstract

Renal tubular cell injury induced by oxalate plays an important role in kidney stone formation. Water containing oxygen nano-bubbles (nanometer-sized bubbles generated from oxygen micro-bubbles; ONB) has anti-inflammatory effects. Therefore, we investigated the inhibitory effects of ONB water on kidney stone formation in ethylene glycol (EG)-treated rats. We divided 60 rats, aged 4 weeks, into 5 groups: control, the water-fed group; 100 % ONB, the 100 % ONB water-fed group; EG, the EG treated water-fed group; EG + 50 % ONB and EG + 100 % ONB, water containing EG and 50 % or 100 % ONB, respectively. Renal calcium oxalate (CaOx) deposition, urinary excretion of N-acetyl-β-D-glucosaminidase (NAG), and renal expression of inflammation-related proteins, oxidative stress biomarkers, and the crystal-binding molecule hyaluronic acid were compared among the 5 groups. In the control and 100 % ONB groups, no renal CaOx deposits were detected. In the EG + 50 % ONB and EG + 100 % ONB groups, ONB water significantly decreased renal CaOx deposits, urinary NAG excretion, and renal monocyte chemoattractant protein-1, osteopontin, and hyaluronic acid expression and increased renal superoxide dismutase-1 expression compared with the EG group. ONB water substantially affected kidney stone formation in the rat kidney by reducing renal tubular cell injury. ONB water is a potential prophylactic agent for kidney stones.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23754513     DOI: 10.1007/s00240-013-0576-5

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  33 in total

Review 1.  The protean face of renal sarcoidosis.

Authors:  Ursula Göbel; Ralph Kettritz; Wolfgang Schneider; Friedrich C Luft
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

Review 2.  Hyaluronan and homeostasis: a balancing act.

Authors:  Markku I Tammi; Anthony J Day; Eva A Turley
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

3.  Free-radical generation from collapsing microbubbles in the absence of a dynamic stimulus.

Authors:  Masayoshi Takahashi; Kaneo Chiba; Pan Li
Journal:  J Phys Chem B       Date:  2007-01-25       Impact factor: 2.991

Review 4.  Epidemiology of stone disease.

Authors:  Gary C Curhan
Journal:  Urol Clin North Am       Date:  2007-08       Impact factor: 2.241

5.  Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis.

Authors:  Yasunori Itoh; Takahiro Yasui; Atsushi Okada; Keiichi Tozawa; Yutaro Hayashi; Kenjiro Kohri
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

6.  Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors.

Authors:  H-S Huang; J Chen; C-F Chen; M-C Ma
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

7.  Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium.

Authors:  R de Water; C Noordermeer; A B Houtsmuller; A L Nigg; T Stijnen; F H Schröder; D J Kok
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

8.  Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4.

Authors:  Thomas Boettger; Christian A Hübner; Hannes Maier; Marco B Rust; Franz X Beck; Thomas J Jentsch
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

9.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

10.  Effects of impaired functional domains of osteopontin on renal crystal formation: Analyses of OPN transgenic and OPN knockout mice.

Authors:  Shuzo Hamamoto; Shintaro Nomura; Takahiro Yasui; Atsushi Okada; Masahiro Hirose; Hideo Shimizu; Yasunori Itoh; Keiichi Tozawa; Kenjiro Kohri
Journal:  J Bone Miner Res       Date:  2009-12-14       Impact factor: 6.741

View more
  6 in total

1.  Oxygen ultra-fine bubbles water administration prevents bone loss of glucocorticoid-induced osteoporosis in mice by suppressing osteoclast differentiation.

Authors:  T Noguchi; K Ebina; M Hirao; T Morimoto; K Koizumi; K Kitaguchi; H Matsuoka; T Iwahashi; H Yoshikawa
Journal:  Osteoporos Int       Date:  2016-11-28       Impact factor: 4.507

2.  Is oxidative stress related to childhood urolithiasis?

Authors:  Nilufer Göknar; Faruk Oktem; Engin Arı; Aysegul Doğan Demir; Emel Torun
Journal:  Pediatr Nephrol       Date:  2014-02-14       Impact factor: 3.714

3.  Prophylactic effects of quercetin and hyperoside in a calcium oxalate stone forming rat model.

Authors:  Wei Zhu; Yun-fei Xu; Yuan Feng; Bo Peng; Jian-ping Che; Min Liu; Jun-hua Zheng
Journal:  Urolithiasis       Date:  2014-08-02       Impact factor: 3.436

4.  Effects of ozone nano-bubble water on periodontopathic bacteria and oral cells - in vitro studies.

Authors:  Sae Hayakumo; Shinichi Arakawa; Masayoshi Takahashi; Keiko Kondo; Yoshihiro Mano; Yuichi Izumi
Journal:  Sci Technol Adv Mater       Date:  2014-09-08       Impact factor: 8.090

5.  Administration of Oxygen Ultra-Fine Bubbles Improves Nerve Dysfunction in a Rat Sciatic Nerve Crush Injury Model.

Authors:  Hozo Matsuoka; Kosuke Ebina; Hiroyuki Tanaka; Makoto Hirao; Toru Iwahashi; Takaaki Noguchi; Koji Suzuki; Shunsuke Nishimoto; Tsuyoshi Murase; Hideki Yoshikawa
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

6.  Nanobubbles Water Curcumin Extract Reduces Injury Risks on Drop Jumps in Women: A Pilot Study.

Authors:  I-Lin Wang; Chien-Yu Hsiao; Yu-Heng Li; Fan-Bo Meng; Chi-Chang Huang; Yi-Ming Chen
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-01       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.